What is Ozempic?
Ozempic is a prescription medication that has gained significant attention in recent years for its effectiveness in treating type 2 diabetes and aiding weight loss. Ozempic belongs to a class of drugs called GLP-1 receptor agonists. Its active ingredient, semaglutide, works by mimicking a hormone that regulates blood sugar levels and appetite.
In the UK, Ozempic is only available on prescription as a drug to treat type 2 diabetes.
Administered as a once-weekly injection, Ozempic helps lower blood glucose levels by stimulating insulin production and reducing glucagon secretion.
While licensed in the UK only for diabetes management, Ozempic has also shown promising results in helping individuals with obesity achieve significant weight reduction. However, it's important to note that Ozempic should only be used under the guidance of a healthcare professional and is not a substitute for a healthy diet and regular exercise.
Can you buy Ozempic for weight loss in the UK?
Ozempic is primarily licensed in the UK for treating type 2 diabetes, not as a weight loss medication. Wegovy uses the same active ingredient as Ozempic that has been approved for weight loss in the UK. It's also important to note that Ozempic is only available with a prescription and cannot be purchased over the counter nor online.
There are other weight loss injection drugs available, the most similar to Ozempic is Wegovy, which uses the same active ingredient – Semaglutide. The other popular weight loss injection drug in the UK is Mounjaro which contains Tirzepatide.
If you're interested in using weight loss injections for weight loss, you should consult with a healthcare professional, or speak to our clinical team, who can assess your individual situation and determine if it's an appropriate treatment option for you.
How does Ozempic work?
Ozempic, also known by its generic name semaglutide, is a revolutionary medication that has gained popularity for its effectiveness in managing type 2 diabetes and promoting weight loss.
This injectable drug works by mimicking a hormone called GLP-1 (glucagon-like peptide-1), which is naturally produced in the body. When administered, Ozempic binds to GLP-1 receptors, triggering a cascade of effects that help regulate blood glucose levels and appetite. It stimulates the pancreas to produce more insulin when blood glucose is high, slows down the emptying of the stomach to promote feelings of fullness, and reduces the production of glucose in the liver.
Additionally, Ozempic acts on the brain's appetite control centers, helping to curb hunger and reduce overall food intake. This multifaceted approach not only aids in blood sugar management but also contributes to significant weight loss in many patients, making Ozempic a powerful tool in the fight against diabetes and obesity.
How effective is Ozempic?
Clinical trials have demonstrated that patients using Ozempic experience significant improvements in blood sugar control, with many achieving their target HbA1c levels. The drug's ability to mimic the effects of GLP-1, a hormone that regulates blood sugar and appetite, contributes to its efficacy.
Moreover, Ozempic has been found to be particularly effective for weight loss, with users reporting an average weight reduction of 5-10% of their body weight over time. However, it's important to note that individual results may vary, and the drug's effectiveness can be influenced by factors such as diet, exercise, and adherence to the prescribed regimen.
Is Ozempic safe?
Ozempic (semaglutide) has generally been considered safe and effective for its approved uses when prescribed and monitored by a healthcare professional. However, like all medications, it does come with potential side effects and risks. The most common side effects include nausea, vomiting, diarrhea, and constipation, which typically subside over time.
More serious but rare side effects can include pancreatitis, changes in heart rate, and potential thyroid tumors. It's important to note that Ozempic is only approved for use in adults with type 2 diabetes or for chronic weight management in certain individuals, and its safety profile is based on studies in these populations. It is not licensed to be prescribed for weight loss.
What’s the difference between Wegovy and Ozempic?
While Wegovy and Ozempic are both injectable medications containing the active ingredient semaglutide, they serve different primary purposes and are approved for distinct uses.
Ozempic is primarily licensed and prescribed for managing type 2 diabetes, helping patients control their blood sugar levels and reduce the risk of cardiovascular events.
On the other hand, Wegovy is specifically licensed for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity.
Who can take Ozempic?
In the UK, Ozempic is primarily prescribed for adults with type 2 diabetes to help manage blood sugar levels and reduce the risk of major cardiovascular events.
However, not everyone is a suitable candidate for this medication. Typically, Ozempic is recommended for individuals who have not achieved adequate glycemic control with diet, exercise, and other diabetes medications.
In the UK, Ozempic is not licensed as a weight loss injection. For the purposes of weight loss, Mounjaro and Wegovy are common alternatives.
Can I take Ozempic as a non-diabetic?
No – in the UK, Ozempic cannot be prescribed to non-diabetics, as it’s only licensed in the UK for managing type 2 diabetes. Wegovy, which uses the same active ingredient as Ozempic, is a licenced medication in the UK for weight loss.
Ozempic side effects
While Ozempic has proven effective for many in managing type 2 diabetes and aiding weight loss, it's important to be aware of potential side effects.
The most common issues reported include nausea, vomiting, diarrhea, and constipation, which typically subside as the body adjusts to the medication.
Some users may experience headaches, fatigue, or dizziness. In rare cases, more serious side effects can occur, such as pancreatitis or changes in heart rate. It's crucial to note that Ozempic may also impact the absorption of other medications.
Other weight loss treatments
Wegovy
Wegovy, a once-weekly injectable weight loss drug containing the active ingredient semaglutide, works by mimicking a hormone called GLP-1 that targets areas of the brain involved in appetite regulation. Clinical trials have shown impressive results, with patients losing an average of 17.5% of their body weight over 68 weeks when taking up to 2.4mg strength. A higher strength of Wegovy 7.2mg is currently undergoing authorisation review and once granted and available it has been show to achieve 20.7% reduction after 72 weeks.
Unlike other weight loss solutions, Wegovy addresses the biological factors that make weight loss challenging, helping users feel fuller for longer and reducing cravings.
Mounjaro
Mounjaro, developed by Eli Lilly and Company, is a once-weekly injectable that combines the effects of two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
By mimicking these naturally occurring hormones, Mounjaro helps regulate blood sugar levels, increase insulin sensitivity, and reduce appetite. Clinical trials have shown remarkable results, with many patients experiencing significant improvements in their blood glucose control and substantial weight loss.
While it's not a magic solution, Mounjaro represents a promising advancement in the treatment of these chronic conditions, offering hope to millions of people worldwide seeking better health outcomes and improved quality of life.
